Status
Conditions
Treatments
About
This randomized controlled trial (RCT) aimed to evaluate the effects of Nordic walking (NW) on gait kinematics, musculoskeletal pain, and quality of life in pregnant women.
Full description
Healthy pregnant women (N=50), aged 20-40 years and between 13 and 28 weeks of gestation, experiencing mild to moderate musculoskeletal pain, will be recruited. Participants will be randomized into either an intervention group (NW training) or a control group receiving standard prenatal care. The intervention group will undergo a 4-week learning phase followed by an 8-week NW program (3 sessions per week, 45 minutes per session), led by a certified instructor. Outcome measures will be assessed at baseline, after 4 weeks, and post-intervention (8 weeks), including spatiotemporal gait parameters (will be assessed using the GAITRite system), musculoskeletal pain (will be measured via Visual Analog Scale, VAS), and quality of life (will be measured using the SF-36 Health Survey).
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
55 participants in 2 patient groups
Loading...
Central trial contact
Wafaa M Amin, PHD; Wafaa Mahmoud Amin, PHD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal